Though billionaire James Dinan‘s York Capital Management manages regulatory assets worth over $25 billion, its latest 13F filing reveals that less......
(read more)
September 26 - Hedge Fund Analysis, Hedge Funds, News - Comments
Biotechs have had a very tough year, though the healthcare sector as a whole has managed to rebound into the green year–to-date. While the iShares......
(read more)
August 27 - Hedge Funds, News - Comments
After surging almost non-stop to $49 per barrel from $40, WTI futures are now 2% in the red while the broader indexes are pretty much flat in pre-market......
(read more)
August 22 - Market Movers, News - Comments
No matter how much things have changed over the past several years, Wall Street remains a place that is dominated by men. However, one woman who managed......
(read more)
July 20 - Hedge Fund Analysis, Hedge Funds, News - Comments
The markets opened higher today before sliding slightly into the red as investors await June’s data on import and export prices, the Treasury’......
(read more)
July 13 - Market Movers, News - Comments
The benchmark S&P 500 index has jumped six points on Monday, setting a new all-time high as last week’s strong jobs report continues to buoy market......
(read more)
July 11 - Market Movers, News - Comments
Redmile Group is a San Francisco-based, healthcare-focused hedge fund founded and managed by Jeremy Green, an Oxford alum with more than 20 years of experience......
(read more)
June 3 - Hedge Fund Analysis, Hedge Funds, News - Comments
The US stock market plunged after the bell on the back of April nonfarm payrolls data, which showed that 160,000 jobs were created last month, versus......
(read more)
May 6 - Market Movers, News - Comments
The markets are sliding on Wednesday after a report from Automatic Data Processing, which shows a decline in the growth of private sector employment.......
(read more)
May 4 - Market Movers, News - Comments
It’s the middle of earnings season and many investors are hungrily dissecting earnings reports and management commentary to get a better view on......
(read more)
April 28 - Market Movers, News - Comments
It’s M&A Thursday, as several major M&A deals have been announced today. Among the companies in the mood for mergers and acquisitions are......
(read more)
April 28 - Market Movers, News - Comments
With the S&P 500 and Dow Jones barely in the green as investors remain concerned about China’s slowing economy, Big Lots, Inc. (NYSE:BIG),......
(read more)
January 12 - Market Movers, News - Comments
Mariner Investment Group is a New York-based investment advisory firm founded by William Michaelcheck in 1992. Apart from its headquarters in New York......
(read more)
November 13 - Hedge Fund Analysis, Hedge Funds, News - Comments
Founded in 1987, Apex Capital Management invests mainly in companies that have market caps of up to $10 billion and is currently overseeing $6.5 billion......
(read more)
October 28 - Hedge Funds, News - Comments
The small patient pool for medullary thyroid cancer, or MTC, isn’t going to move the needle for a large pharmaceutical company. But Exelixis, Inc......
(read more)
September 17 - News - Comments
At the moment, there are a multitude of metrics shareholders can use to monitor stocks. A pair of the most useful are hedge fund and insider trading sentiment......
(read more)
September 10 - News - Comments
Should investors be bullish on Incyte Corporation (NASDAQ:INCY)? In the 21st century investor’s toolkit, there are many gauges shareholders can use......
(read more)
August 30 - News - Comments
In the eyes of many investors, hedge funds are seen as overrated, old financial tools of a forgotten age. Although there are over 8,000 hedge funds in......
(read more)
August 28 - News - Comments
In today’s marketplace, there are a multitude of gauges market participants can use to analyze their holdings. Two of the most innovative are hedge......
(read more)
August 27 - News - Comments
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) investors: listen up. In the 21st century investor’s toolkit, there are tons of metrics shareholders can use......
(read more)
August 26 - News - Comments
Is Medivation Inc (NASDAQ:MDVN) a buy? In today’s marketplace, there are a multitude of methods shareholders can use to monitor the equity markets.......
(read more)
August 25 - News - Comments
If you were to ask many investors, hedge funds are assumed to be useless, old investment tools of a period lost to current times. Although there are more......
(read more)
August 23 - News - Comments
There’s been plenty of buzz lately about the continuing saga of the possible buyout of Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) by Amgen, Inc. (......
(read more)
August 23 - News - Comments
Johnson & Johnson (NYSE:JNJ) completed its acquisition of privately held Aragon Pharmaceuticals earlier this week. Plans for the deal were first announced......
(read more)
August 23 - News - Comments
There are many types of biotech companies out there with tremendous value. Today, I will focus on the ones that target prostate cancer. Investors should......
(read more)
August 1 - News - Comments
Biotech is booming these days. But that’s not a new story by any means. Biotech stocks as a group have done very well over the past several years......
(read more)
July 24 - News - Comments
There’s a lot to notice from Johnson & Johnson (NYSE:JNJ)’s earnings — the company announced a very solid quarter. But the one thing that......
(read more)
July 17 - News - Comments
Are investors hitting the brakes on biotech? The biotech sector’s one of the most boom-or-bust areas for investors, where fortunes can be won or......
(read more)
June 24 - News - Comments
With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the......
(read more)
April 27 - News - Comments
When it comes to health care companies, there’s no bigger name than the largest firm in the business: Johnson & Johnson (NYSE:JNJ) . What doesn......
(read more)
April 7 - News - Comments
The biotech sector is perhaps the most volatile and risk-prone sector in the market, but investors still love it. Medical science is leaping forward and......
(read more)
March 26 - News - Comments
When it comes to health care companies, there’s no bigger name than the largest firm in the business: Johnson & Johnson (NYSE:JNJ). What doesn......
(read more)
March 13 - News - Comments
Now more than ever, a comfortable retirement depends on secure, stable investments. Unfortunately, the right stocks for retirement won’t just fall......
(read more)
March 11 - News - Comments
As I commented last week, cancer statistics are both staggering and disappointing. Although cancer deaths per 100,000 people have been on the downswing......
(read more)
March 5 - News - Comments
Normally we have a nice blend of health-care events to take notice of each week. This week I’m steering you squarely toward the biotechnology sector......
(read more)
February 24 - News - Comments
Earnings season is now starting to wind down, with most companies already having reported their quarterly results. But there are still some companies......
(read more)
February 22 - News - Comments
Johnson & Johnson (NYSE:JNJ) may offer well-known personal-care products such as Listerine and Neutrogena, but it also boasts an impressive portfolio......
(read more)
February 20 - News - Comments